MedPath

Prospective exploratory study for evaluating the efficacy of taking ENEVO long term for gastric cancer patients after gastrectomy.

Not Applicable
Recruiting
Conditions
gastric cancer
Registration Number
JPRN-UMIN000017913
Lead Sponsor
Fujita Health University Hospital
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
60
Inclusion Criteria

Not provided

Exclusion Criteria

1)The patient who are overlapped cancer of synchronism or metachronous, or who are multiple cancer. 2)The patient who contraindicated of ENEVO. 3)The patient who are participating in other clinical trials. 4)The patient who is not suitable for this clinical study by researchers. 5)The patient who experienced severe postoperative complications(more than Grade3 of Clavien-Dindo classification).

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath